Fluidic Analytics Secures £1.56 Million to Develop New Protein Characterisation Technology
January 12, 2015
Fluidic Analytics has developed a proprietary technology to characterise proteins in a rapid, accurate and cost-effective manner. The technology is based on research conducted at the University of Cambridge and has high-value applications including identifying markers that indicate the onset of diseases in the human body. In contrast to DNA, whose sequence provides information on [...]
Protea launches new tissue analytics software and workflow
January 12, 2015
SAN FRANCISCO -- Protea Biosciences Group, Inc. (PRGB) ("Protea") announced today that it has developed a new software platform, known as "Histology Guided Mass Spec Imaging (HG-MSI)", that enables pathologists to combine traditional microscopy and histology with high resolution mass spectrometry molecular imaging. The Company made the announcement today while presenting at the Biotech Showcase(TM) [...]
January 12, 2015
SANTA CLARA, Calif. -- Affymetrix, Inc., (NASDAQ:AFFX) today announced that based on preliminary, unaudited financial data, the Company expects total revenue for the fourth quarter of 2014 to be approximately $93 million. For fiscal 2014, the Company expects total revenue of approximately $348 million, representing a 9% growth over the prior year, after adjusting for [...]
January 12, 2015
GLOSTRUP, Denmark -- Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, and Cell Signaling Technology (CST), a worldwide provider of antibodies, today announced that they have entered into a strategic partnership to supply antibodies for use in Dako-branded companion diagnostics products. "We are pleased to work with CST in the development [...]
New 50 Microliter Electronic Pipettes
January 12, 2015
INTEGRA has expanded its popular VIAFLO II electronic pipette range. Often requested by users of PCR applications, the new 50 µl models perfectly fill the gap between the 0.5-12.5 µl and 5-125 µl ranges. Now available for single-, 8-, 12- and 16-channel VIAFLO II pipettes, the new models deliver optimized precision pipetting in the volume [...]
Seahorse Bioscience Reaches 500 Scientific Paper Citations in 2014
January 12, 2015
Billerica, MA -– Seahorse Bioscience, the industry leader in metabolic analyzers and assay kits for measuring real time cell metabolism, reached its 500th citation in a scientific journal for the year 2014 in a paper published in Nature Medicine, November 24, 2014. The paper, “Chronic Enrichment of Hepatic Endoplasmic Reticulum-Mitochondria Contact Leads to Mitochondrial Dysfunction [...]
January 12, 2015
ROCKVILLE, Md. & SAN DIEGO -- Lockheed Martin (NYSE: LMT) and Illumina, Inc. (NASDAQ: ILMN) today announced a new strategic alliance to collaborate on scalable and affordable genomics solutions to provide personalized health care for national populations. Genomics is the science of studying genomes or DNA. Applied to health care, analyzing a person's DNA sequence [...]
January 12, 2015
SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today introduced the GenetiSure Pre-Screen Kit, a high-throughput oligonucleotide microarray for screening aneuploidy and other genomic aberrations in the 5- to 10-Mb range from single cells in three- and five-day embryos. Agilent's kit allows for a turnaround time of less than eight hours from DNA extraction [...]
BioLife Solutions Reports Preliminary Revenue for 2014
January 12, 2015
BOTHELL, WA —- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues (“BioLife” or the “Company”), today announced preliminary revenue for the fourth quarter and full year 2014 and a recap of operational accomplishments. [...]
January 12, 2015
Hilden, Germany -– QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) announced today the CE-IVD marking of its novel liquid biopsy-based companion diagnostic that analyzes circulating nucleic acids obtained from blood samples to assess an important genomic mutation in patients with non-small cell lung cancer (NSCLC), the most common form of this cancer. The registration, which [...]

